Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1988 Aug;43(8):585–590. doi: 10.1136/thx.43.8.585

Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.

G Ricevuti 1, A Mazzone 1, E Uccelli 1, G Gazzani 1, G B Fregnan 1
PMCID: PMC461392  PMID: 3051508

Abstract

Twenty four patients with acute infective exacerbations of chronic bronchitis received amoxycillin alone or in combination with erdosteine (a mucolytic agent) for a week in a double blind, placebo controlled study. Clinical assessment scores, body temperature, serum and sputum amoxycillin concentrations, and sputum culture results were recorded in each group. Erdosteine significantly increased antibiotic concentrations in sputum but not in serum. The combined treatment also caused a more rapid decrease in sputum viscosity and in body temperature and faster sterilisation of the sputum. These results show that erdosteine increases amoxycillin concentration in sputum in patients with acute exacerbations of chronic bronchitis. This effect may be due to a reduction in the viscosity of the bronchial secretions produced by erdosteine.

Full text

PDF
585

Images in this article

588Image
on p.588
588Image
on p.588

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach P. H., Leary W. P. The effects of bromhexine on oxytetracycline penetrance into sputum. S Afr Med J. 1972 Oct 14;46(41):1512–1514. [PubMed] [Google Scholar]
  2. Bergogne-Berezin E., Pierre J., Dournovo P. Etude de l'influence d'un agent mucolytique (bromhexine) sur le passage de l'érythromycine dans les sécrétions bronchiques. Therapie. 1979 Nov-Dec;34(6):705–711. [PubMed] [Google Scholar]
  3. Buergi H., Regli J., Medici T. Observation on the problems accompanying antibiotic treatment in bronchitis with recurrent infection. Arzneimittelforschung. 1969 May;19(5):776–777. [PubMed] [Google Scholar]
  4. Campbell M. J. Tetracycline levels in bronchial secretions. J Clin Pathol. 1970 Jul;23(5):427–434. doi: 10.1136/jcp.23.5.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carlqvist J., Westerlund D. Determination of amoxicillin in body fluids by reversed-phase liquid chromatography coupled with a post-column derivatization procedure. J Chromatogr. 1979 Nov 11;164(3):373–381. doi: 10.1016/s0378-4347(00)81238-4. [DOI] [PubMed] [Google Scholar]
  6. Gobetti M., Pedrazzoli A., Bradamante S. DL-S-(2-[N-3-(2-oxo-tetrahydrothienyl)acetamido])-thioglycolic acid: a novel mucolytic agent of the class of homocysteine thiolactone derivatives. Farmaco Sci. 1986 Jan;41(1):69–79. [PubMed] [Google Scholar]
  7. Heaf D. P., Webb G. J., Matthew D. J. In vitro assessment of combined antibiotic and mucolytic treatment for Pseudomonas aeruginosa infection in cystic fibrosis. Arch Dis Child. 1983 Oct;58(10):824–826. doi: 10.1136/adc.58.10.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LAWSON D., SAGGERS B. A. N.A.C. AND ANTIBIOTICS IN CYSTIC FIBROSIS. Br Med J. 1965 Jan 30;1(5430):317–317. doi: 10.1136/bmj.1.5430.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mendelman P. M., Smith A. L., Levy J., Weber A., Ramsey B., Davis R. L. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis. 1985 Oct;132(4):761–765. doi: 10.1164/arrd.1985.132.4.761. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES